Metabolic syndrome in patients with hypertension attending a family practice clinic in Jordan;Le syndrome métabolique chez des patients hypertendus fréquentant un service de médecine familiale en Jordanie

Eastern Mediterranean Health Journal

Volumn 16, Issue 4, 2010, Pages 375-380

  Yasein, N ^a   Ahmad, M ^a   Matrook, F ^a   Nasir, L ^b   Froelicher, E S ^c  

^a UNIVERSITY OF JORDAN   (Jordan)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GENERAL PRACTICE; HUMAN; HYPERTENSION; JORDAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIMARY MEDICAL CARE; RISK FACTOR; SCREENING; WAIST CIRCUMFERENCE; AGED; CHI SQUARE DISTRIBUTION; COMPLICATION; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; MASS SCREENING; MIDDLE AGED; OBESITY; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; SEX RATIO; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FAMILY PRACTICE; FEMALE; HUMANS; HYPERTENSION; JORDAN; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PRIMARY HEALTH CARE; RISK FACTORS; SEX DISTRIBUTION;

EID: 77953756821     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2010.16.4.375     Document Type: Article

References (22)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association, 2001, 258:2486-97.
2. Schillaci G et al. Prognostic value of the metabolic syndrome in essential hypertension. Journal of the American College of Cardiology, 2004, 4310:1817-22.
3. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. Journal of hypertension, 2003, 21:1011-53.
4. Braunwald E et al., eds. Braunwald's heart disease: a textbook of cardiovascular medicine, 7th ed. Philadelphia, Saunders, 2005:1953.
5. Sorkhou EI et al. Prevalence of metabolic syndrome among hypertensive patients attending a primary care clinic in Kuwait. Medical principles and practice, 2004, 131:39-42.
6. Al-Nozha M et al. Metabolic syndrome in Saudi Arabia. Saudi medical journal, 2005, 26:1360-6.
7. Abdul-Ghani MA et al. High frequency of pre-diabetes, undiagnosed diabetes and metabolic syndrome among overweight Arabs in Israel. Israel Medical Association journal, 2005, 7:143-7.
8. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: frequency in worldwide populations. Endocrinology and metabolism clinics of North America, 2004, 33(2):351-375.
9. Kozan O et al. Prevalence of the metabolic syndrome among Turkish adults. European journal of clinical nutrition, 2007, 61(4):548-53.
10. Ozsahin AK et al. Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes nutrition and metabolism, 2004, 17(4):230-4.
11. Soysal A et al. The prevalence of metabolic syndrome among young adults in Izmir, Turkey. Anadolu kardiyoloji dergisi, 2005, 5(3):196-201.
12. Ajlouni K, Jaddou H, Batieha A. Diabetes and impaired glucose tolerance in Jordan: prevalence and associated risk factors. Journal of internal medicine, 1998, 244:317-23.
13. Ajlouni K, Jaddou H, Batieha A. Obesity in Jordan. International journal of obesity and related metabolic disorders, 1998, 22:624-8.
14. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, World Health Organization, 1998.
15. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of WHO consultation: part 1: diagnoses and classification of diabetes mellitus. Geneva, World Health Organization, 1999.
16. Cardiovascular death and disability can be reduced more than 50 per cent. Geneva, World Health Organization press release WHO/83, 17 October, 2002.
17. Czernichow S et al. Metabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure. A report from the SU.VI.MAX vascular study. American journal of hypertension, 2005, 18(9 Pt 1):1154-60.
18. Peters A. The broadening domain of the metabolic syndrome. Medscape, 27 July, 2005 (http://cme.medscape.com/ viewarticle/508282?rss, accessed 4 October 2009).
19. Mule G et al. Influence of metabolic syndrome on hypertension related target organ damage. Journal of internal medicine, 2005, 257:503-13.
20. Kip KE et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation, 2004, 109:706.
21. Yasein N. Cardiovascular risk and anthropometric measurement in women attending family practice. Jordan medical journal, 2005, 39:106-11.
22. Després JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. British medical journal, 2001, 322:716-20.